HLA-G and bone disorder: The health insurance coverage criteria of Lixelle® in Japan requires: (1) surgical or biopsy confirmation of β2-microglobulin-induced amyloid deposition, (2) dialysis vintage 10 years or longer with a history of carpal tunnel release, and (3) the presence of bone cyst on imaging diagnosis.